Anti-CD20 therapy in systemic lupus erythematosus: A step closer to the clinic

被引：34
作者：
Silverman, GJ [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 02期
关键词：
D O I：
10.1002/art.20857
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：371 / 377
页数：7
相关论文
共 41 条
  • [1] Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
    Anolik, JH
    Barnard, J
    Cappione, A
    Pugh-Bernard, AE
    Felgar, RE
    Looney, RJ
    Sanz, I
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (11): : 3580 - 3590
  • [2] The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
    Anolik, JH
    Campbell, D
    Felgar, RE
    Young, F
    Sanz, I
    Rosenblatt, J
    Looney, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 455 - 459
  • [3] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [4] C1q, autoimmunity and apoptosis
    Botto, M
    Walport, MJ
    [J]. IMMUNOBIOLOGY, 2002, 205 (4-5) : 395 - 406
  • [5] RISK FOR SUSTAINED AMENORRHEA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING INTERMITTENT PULSE CYCLOPHOSPHAMIDE THERAPY
    BOUMPAS, DT
    AUSTIN, HA
    VAUGHAN, EM
    YARBORO, CH
    KLIPPEL, JH
    BALOW, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) : 366 - 369
  • [6] From the bench to the bedside: ways to improve rituximab efficacy
    Cartron, G
    Watier, H
    Golay, J
    Solal-Celigny, P
    [J]. BLOOD, 2004, 104 (09) : 2635 - 2642
  • [7] Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals
    Cassese, G
    Arce, S
    Hauser, AE
    Lehnert, K
    Moewes, B
    Mostarac, M
    Muehlinghaus, G
    Szyska, M
    Radbruch, A
    Manz, RA
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (04) : 1684 - 1690
  • [8] The central and multiple roles of B cells in lupus pathogenesis
    Chan, OTM
    Madaio, MP
    Shlomchik, MJ
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 169 : 107 - 121
  • [9] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    Clynes, RA
    Towers, TL
    Presta, LG
    Ravetch, JV
    [J]. NATURE MEDICINE, 2000, 6 (04) : 443 - 446
  • [10] Sequential therapies for proliferative lupus nephritis
    Contreras, G
    Pardo, V
    Leclercq, B
    Lenz, O
    Tozman, E
    O'Nan, P
    Roth, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) : 971 - 980
12345